- 1. folacin
- [folate and its derivatives. ( CSP )] (UMLS (CSP) C0699376) =Organic Chemical; Pharmacologic Substance; Vitamin =pteridine;
[VT100] VITAMIN B =5-Formyl-5,6,7,8-tetrahydrofolic Acid;
5,10 methylenetetrahydrofolate;
tetrahydrofolate;
folate;
| - 37. Follicular Mixed Cell Lymphoma Stage I
- (UMLS (NCI) C0279955) =Neoplastic Process
|
- 2. folate
- [cofactor for 1-carbon transfer reactions in living systems; deficiency disrupts DNA biosynthesis, manifesting mainly as anemia. ( CSP )] (UMLS (NCI) C0178638) =Organic Chemical; Vitamin ;
=folacin;
| - 38. Follicular Mixed Cell Lymphoma Stage II
- (UMLS (NCI) C0280144) =Neoplastic Process
|
- 3. Folate Biosynthesis
- [The chemical reactions and pathways resulting in the formation of folic acid, pteroylglutamic acid. [GOC:ai] ( GO )] (UMLS (NCI) C1157038) Folate Biosynthesis Pathway;
=Molecular Function | - 39. Follicular Mixed Cell Lymphoma Stage III
- (UMLS (NCI) C0280157) =Neoplastic Process
|
- 4. folate deficiency
- [state in which folate is absent or in diminished amount relative to the normal requirement of an organism or a biologic system. ( CSP )] (UMLS (CSP) C0016412) =Disease or Syndrome =Deficiency of B-complex components;
| - 40. Follicular Mixed Cell Lymphoma Stage IV
- (UMLS (NCI) C0280170) =Neoplastic Process
|
- 5. Folate Hydrolase (Prostate-Specific Membrane Antigen) 1 Gene
- [This gene plays a role in folate metabolism. It is also involved in neuronal transmission. ( NCI )] (UMLS (NCI) C1333570) FOLH1;
FOLH1 Gene =Gene or Genome | - 41. follicular mucinosis
- [A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary (idiopathic) or secondary to mycosis fungoides or reticulosis. ( MSH )] (UMLS (CSP) C0002173) =Disease or Syndrome
|
- 6. Folate Hydrolase 1
- [Prostate-specific membrane antigen (PSMA) is an integral membrane protein that is highly expressed on the surface of prostate epithelial cells and tumor-associated vascular endothelia. It is also expressed on the vascular endothelium of a number of tumor types. PSMA gene has been cloned through detection with a monoclonal antibody raised against the human prostatic carcinoma cell line LNCaP. Subsequently, PSMA gene was shown to be identical to glutamate carboxypepidase II (GCP2) gene, and to encode a type II transmembrane protein with folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALAdase) activity. (from OMIM) ( NCI )] (UMLS (NCI) C0067685) =Amino Acid, Peptide, or Protein; Enzyme
| - 42. Follicular Myxoma
- [A cutaneous myxoma arising from the hair follicle. ( NCI )] (UMLS (NCI) C1336823) Trichogenic Myxoma =Neoplastic Process ;
|
- 7. Folate Metabolism
- [Folate Metabolism involves cellular biotransforming chemical modifications of folic acid by enzymatic activity. ( NCI )] (UMLS (NCI) C1157079) Folic Acid Metabolism;
Folic Acid Metabolosm =Molecular Function | - 43. Follicular Ovarian Cell
- [A cell located in the epithelium of the ovarian follicles. ( NCI )] (UMLS (NCI) C1182635) =Cell
|
- 8. Folate Receptor 1 (Adult) Gene
- [This gene is involved in the mediation of 5-methyltetrahydrofolate delivery to the cellular interior. ( NCI )] (UMLS (NCI) C1414662) FOLR1;
FOLR1 Gene =Gene or Genome | - 44. follicular phase
- [The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION. ( MSH )] (UMLS (CSP) C0016434) =Temporal Concept
|
- 9. FOLATE-DEFICIENCY ANEMIA
- (UMLS (ICD9CM) C0151482) =Disease or Syndrome ;
| - 45. Follicular Small Cleaved Cell Lymphoma Stage I
- (UMLS (NCI) C0279954) =Neoplastic Process
|
- 10. FOLD IN DESCEMET MEMBRAN
- [ ] (UMLS (ICD9CM) C0155116) =Anatomical Abnormality ;
| - 46. Follicular Small Cleaved Cell Lymphoma Stage II
- (UMLS (NCI) C0280143) =Neoplastic Process
|
- 11. FOLD OF BOWMAN MEMBRANE
- [ ] (UMLS (ICD9CM) C0155115) =Disease or Syndrome ;
| - 47. Follicular Small Cleaved Cell Lymphoma Stage III
- (UMLS (NCI) C0280156) =Neoplastic Process
|
- 12. folder
- [A context representing the high-level organization of an extract e.g. to group parts of the record by episode, care team, clinical specialty, clinical condition, or source application. Internationally, this kind of organizing structure is used variably: in some centers and systems the folder is treated as an informal compartmentalization of the overall health record; in others it might represent a significant legal portion of the EHR relating to the originating enterprise or team. A folder contains compositions. Folders may be nested within folders. ( HL7V3.0 )] (UMLS (HL7) C1555709) =Idea or Concept =ActClassContainer;
| - 48. Follicular Small Cleaved Cell Lymphoma Stage IV
- (UMLS (NCI) C0280169) =Neoplastic Process
|
- 13. FOLESCUTOL
- (UMLS (NCI) C0304536) =Organic Chemical; Pharmacologic Substance
| - 49. Follicular Variant Translocation Protein 1
- [Expressed in hematopoietic tissues and PHA-stimulated lymphocytes by human FVT1 Gene (SDR Family), the function of 332-aa 36-kDa (precursor) secreted Follicular Variant Translocation Protein 1 is unknown. (NCI) ( NCI )] (UMLS (NCI) C1333629) FVT1;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 14. Folex
- (UMLS (NCI) C0701379) =Organic Chemical; Pharmacologic Substance
| - 50. folliculitis
- [Inflammation of follicles, primarily hair follicles. ( MSH )] (UMLS (CSP) C0016436) =Disease or Syndrome =Hair Diseases;
=Acne Keloid |
- 15. Foliate Papilla
- (UMLS (NCI) C0545785) =Body Part, Organ, or Organ Component
| - 51. Folliculostatin
- [peptide hormone which inhibits pituitary secretion of Follicle Stimulating Hormone; same name has been used for a tumor suppressor protein, do not confuse. ( CSP )] (UMLS (NCI) C0021463) =Amino Acid, Peptide, or Protein; Hormone =Peptide Hormone;
reproductive hormone =activin binding protein;
|
- 16. Folic Acid/Lometrexol/Paclitaxel
- (UMLS (NCI) C1134482) =Therapeutic or Preventive Procedure
| - 52. folliliberin
- [ ] (UMLS (CSP) C0599447) =Biologically Active Substance ;
|
- 17. Foligan
- (UMLS (NCI) C1449504) =Organic Chemical; Pharmacologic Substance
| - 53. Follistatin-Like 3 (Secreted Glycoprotein) Gene
- [This gene plays a role in a variety of processes including transcription. ( NCI )] (UMLS (NCI) C1333581) FSTL3;
FSTL3 Gene =Gene or Genome ;
|
- 18. folk medicine
- [systems of medicine based on cultural beliefs and practices handed down from generation to generation; the concept includes mystical and magical rituals, herbal therapy, and other treatments which may not be explained by modern medicine. ( CSP )] (UMLS (CSP) C0016419) =Therapeutic or Preventive Procedure =alternative medicine;
| - 54. Follistatin-Like 3 Glycoprotein
- [Secreted Follistatin-Like 3 Glycoprotein binds to activin and is highly homologous to follistatin, an activin ligand. It is a member of the follistatin-module protein family, which is composed of extracellular matrix-associated glycoproteins thought to act in a paracrine manner to bind morphogens or growth/differentiation factors and regulate their activity during development. In addition to the t(11;19) translocation in a case of B-cell chronic lymphocytic leukemia from which FSTL3 was isolated, rearrangement of the FSTL3 gene was also observed in a case of B-cell non-Hodgkin lymphoma and in a case of B-cell mantle zone lymphoma, suggesting that FSTL3 may be involved in the leukemogenesis process. ( NCI )] (UMLS (NCI) C0290965) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 19. Follicle
- [Any small spherical group of cells containing a cavity. ( NCI )] (UMLS (HL7) C1571705) Follicular;
=Body Part, Organ, or Organ Component; ;
=Body Part;
| - 55. Follistim
- (UMLS (NCI) C0656730) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 20. follicle
- [(FOL-i-kul) A sac or pouch-like cavity. ( NCI )] (UMLS (NCI) C0221971) =Body Part, Organ, or Organ Component =Hair;
| - 56. Follitropin
- [A therapeutic glycoprotein hormone synthesized by recombinant DNA technology or purified from biological sources, whose endogenous counterpart follicle stimulating hormone (FSH) stimulates and maintains the normal functions of reproductive system in males and females. (NCI04) ( NCI )] (UMLS (NCI) C0724588) Recombinant Follicle Stimulating Hormone;
Therapeutic FSH =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone |
- 21. Follicle Center Lymphoma
- [A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001). ( NCI )] (UMLS (NCI) C0024301) =Neoplastic Process =Lymphoma, Non-Hodgkin;
=Follicular Large Cell Lymphoma;
Follicular Mixed Cell Lymphoma;
Lymphoma, Small Cleaved-Cell, Follicular;
| - 57. FOLLOW-UP EXAM NEC
- [ ] (UMLS (ICD9CM) C0260840) =Finding
|
- 22. Follicle Centre Lymphoma, Follicular Grade I, II, III Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0855123) Stage IV Follicular Lymphoma;
=Neoplastic Process | - 58. FOLLOW-UP EXAM NOS
- [ ] (UMLS (ICD9CM) C0260832) =Finding
|
- 23. Follicular Ameloblastoma
- (UMLS (NCI) C0457530) =Neoplastic Process
| - 59. Follow-up examination following other surgery
- [ ] (UMLS (ICD9CM) C0878736) FOLLOW-UP SURGERY NEC =Finding
|
- 24. follicular atresia
- [The degeneration and resorption of an OVARIAN FOLLICLE before it reaches maturity and ruptures. ( MSH )] (UMLS (CSP) C0016426) =Organ or Tissue Function
| - 60. Follow-up examination following other treatment
- [ ] (UMLS (ICD9CM) C0260838) =Finding
|
- 25. Follicular Bronchitis/Bronchiolitis
- (UMLS (NCI) C1333627) Follicular Hyperplasia of BALT;
Pulmonary Lymphoid Hyperplasia =Disease or Syndrome | - 61. Follow-up examination following psychotherapy and other treatment for mental disorder
- [ ] (UMLS (ICD9CM) C0260836) =Finding
|
- 26. FOLLICULAR CYST OF OVARY
- (UMLS (ICD9CM) C0016429) =Acquired Abnormality
| - 62. Follow-up examination following radiotherapy
- [ ] (UMLS (ICD9CM) C0260834) =Finding
|
- 27. Follicular Dendritic Cell
- [Antigen Presenting Cells (APCs) located in the follicles of secondary lymphoid organs. These dendritic cells are unique because of their location, primarily in lymphoid follicles, and because of their function in retaining antigen molecules for extended periods of time and serving as APCs for B cells. ( NCI )] (UMLS (NCI) C0242245) =Cell
| - 63. Follow-up examination following surgery
- [ ] (UMLS (ICD9CM) C0260833) =Finding
|
- 28. Follicular Dyskeratoma
- (UMLS (NCI) C0334063) =Disease or Syndrome
| - 64. Follow-up examination following surgery, unspecified
- [ ] (UMLS (ICD9CM) C0878734) FOLLOW-UP SURGERY NOS =Finding
|
- 29. follicular epithelial cell
- [ ] (UMLS (CSP) C0598536) =Cell ;
| - 65. Follow-up examination following treatment of fracture
- [ ] (UMLS (ICD9CM) C0481525) =Finding
|
- 30. Follicular Large Cell Lymphoma
- [(foll-IK-yew-lar large cell lim-FO-ma) A rare type of non-Hodgkin's lymphoma (cancer of the lymphatic system) with large cells that look cleaved (split) or non-cleaved under the microscope. It is an indolent (slow-growing) type of lymphoma. ( NCI )] (UMLS (NCI) C0079745) =Neoplastic Process =Follicle Center Lymphoma;
histiocytic lymphoma;
Intermediate Grade Lymphoma;
| - 66. Follow-up examination following treatment with high-risk medication, not elsewhere classified
- [ ] (UMLS (ICD9CM) C0302433) =Finding
|
- 31. Follicular Large Cell Lymphoma Stage I
- (UMLS (NCI) C0279956) =Neoplastic Process
| - 67. FOLLOW-UP VAG PAP SMEAR
- [ ] (UMLS (ICD9CM) C0878735) Follow-up vaginal pap smear =Finding
|
- 32. Follicular Large Cell Lymphoma Stage II
- (UMLS (NCI) C0280146) =Neoplastic Process
| - 68. Following
- [Subsequent; immediately following in time or order. ( NCI )] (UMLS (NCI) C0332282) =Temporal Concept
|
- 33. Follicular Large Cell Lymphoma Stage III
- (UMLS (NCI) C0280159) =Neoplastic Process
| - 69. followup study
- [Study in which persons exposed to risk or given a designated preventive or therapeutic regimen are observed over a period or at intervals to determine the outcome of the exposure or regimen. ( NCI )] (UMLS (CSP) C0016441) =Research Activity
|
- 34. Follicular Large Cell Lymphoma Stage IV
- (UMLS (NCI) C0280172) =Neoplastic Process
| - 70. Follutein
- (UMLS (NCI) C0309130) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 35. Follicular Lymphoma Variant Translocation 1 Gene
- [This gene plays a role in glycosphingolipid metabolism. ( NCI )] (UMLS (NCI) C1333583) FVT1;
FVT1 Gene =Gene or Genome ;
| - 71. folylpolyglutamate synthase
- [ ] (UMLS (CSP) C0060626) =Amino Acid, Peptide, or Protein; Enzyme =acid aminoacid ligase;
|
- 36. Follicular Mixed Cell Lymphoma
- [A low-grade malignant lymphoma of follicular pattern in which there is no clear preponderance of one cell type (small or large) over another. The large cells, cleaved or noncleaved, are often 2-3 times larger in diameter than normal lymphocytes. ( MSH )] (UMLS (NCI) C0079758) =Neoplastic Process =Follicle Center Lymphoma;
Lymphoma, Mixed-Cell;
Low Grade Lymphoma;
| |
home
